Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Podolec, J. Siekaniec (Cracow, Poland). Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system]. Eur Respir J 2010; 36: Suppl. 54, 2028

Member's Comments

No comment yet.

Related content which might interest you: Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Effective and efficient nebulization of alpha1-proteinase inhibitor (alpha1-PI) for inhalation therapy using the AKITA2® APIXNEBÔ nebulizer system Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I Year: 2010 Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (160/4.5mcg) Spiromax® and BF (200/6mcg) Turbuhaler® following two inhalations (+/– charcoal [char] block) in healthy volunteers (HV) Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Pharmacokinetics (PK) and safety of budesonide plus formoterol (BF) (320/9mcg) Spiromax® and BF (400/12mcg) Turbuhaler® following two inhalations (+/– charcoal [char] block) in healthy volunteers (HV) Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 Effects on the respirable dose < 3.3 µm of an isotonic DSCG inhalation solution (IsoCROM) comparing different nebuliser systems mimicking 3 year old childrens' breathing patterns Source: Eur Respir J 2007; 30: Suppl. 51, 460s Year: 2007 Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM) Source: Eur Respir J 2006; 28: Suppl. 50, 212s Year: 2006 Study of the use of Chartis® pulmonary assessment system to optimize subject selection for endobronchial lung volume reduction (ELVR) – Results and subgroup analysis Source: Annual Congress 2011 - Endoscopic lung volume reduction: hype or hope? Year: 2011 Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 2: Portable battery-compressor Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012 Comparative in vitro performance of a new re-usable breath-actuated nebulizer (BAN) with other high performance systems intended for domiciliary use – 1: Table-top compressors Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012 Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 LATE-BREAKING ABSTRACT: Effect of inhalation profiles and throat geometries on predicted lung deposition of budesonide and formoterol (BF) when inhaled through two different devices Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Effect of nebuliser position on aerosol performance during high flow nasal therapy Source: International Congress 2018 – New tools for managing respiratory failure Year: 2018 Comparison between SCOT-15® and Perfadex® as lung preservation solutions Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations Year: 2011 In-vitro emitted dose characteristics of combination budesonide / formoterol tubuhaler using patient inhalation profiles Source: International Congress 2015 – Lung function: waiting to exhale... Year: 2015 Valved holding chambers (VHCs) can have different medication delivery performance as a function of delay interval following actuation of the pressurized metered dose inhaler (pMDI) Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014 Tolerance of nebulised gentamicin in adult bronchiectasis – A single centre study Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012 Effect of I:E ratio on the respirable delivered dose from nebulizers Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Pharmacokinetics of tobramycin nebulizer solution (300mg/4ml) administered by Pari e-Flow rapid vs Pari LC plus nebulizer in patients with cystic fibrosis and Pseudomonas aeruginosa infection Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012